Article info
Clinical trial
Sentinel lymph node mapping versus sentinel lymph node mapping with systematic lymphadenectomy in endometrial cancer: an open-label, non-inferiority, randomized trial (ALICE trial)
- Correspondence to Dr Glauco Baiocchi, Gynecologic Oncology, AC Camargo Cancer Center, São Paulo 01509-010, Brazil; glauco.baiocchi{at}accamargo.org.br
Citation
Sentinel lymph node mapping versus sentinel lymph node mapping with systematic lymphadenectomy in endometrial cancer: an open-label, non-inferiority, randomized trial (ALICE trial)
Publication history
- Accepted February 14, 2022
- First published March 2, 2022.
Article Versions
- You are currently viewing a Previous version of this article (2 March 2022).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.